Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Open Forum Infectious Diseases
|
July 19, 2018
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
Zheng Quan Toh, Kathleen Wen Bei Cheow, Fiona M Russell, et al.
The Lancet Regional Health. Western Pacific
|
June 26, 2023
A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: an retrospective cohort study in Fiji
Rita Reyburn, Evelyn Tuivaga, Tupou Ratu, et al.
Plos Medicine
|
November 12, 2019
Oxygen systems to improve clinical care and outcomes for children and neonates: A stepped-wedge cluster-randomised trial in Nigeria
Hamish R Graham, Ayobami A Bakare, Adejumoke I Ayede, et al.
Vaccines
|
December 5, 2019
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
Zheng Quan Toh, Jennie Kosasih, Fiona M Russell, et al.
The Lancet Regional Health. Western Pacific
|
December 25, 2023
Impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia hospitalisations in Mongolia: a time series analysis
Kirsten Fagerli, Munkhchuluun Ulziibayar, Bujinlkham Suuri, et al.
Vaccine
|
December 4, 2018
Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
Catherine Satzke, Eileen M Dunne, Molina Choummanivong, et al.
The Lancet Regional Health. Western Pacific
|
September 16, 2021
Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study
Jocelyn Chan, Tuya Mungun, Purevsuren Batsaixan, et al.
Plos One
|
April 3, 2020
Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys
Eleanor F G Neal, Cattram D Nguyen, Felista T Ratu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2016
Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study
Zheng Quan Toh, Fiona M Russell, Rita Reyburn, et al.
The Lancet. Microbe
|
November 1, 2024
Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2-59 months in Mongolia: an active pneumonia surveillance programme
Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Open Forum Infectious Diseases
|
July 19, 2018
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
Zheng Quan Toh, Kathleen Wen Bei Cheow, Fiona M Russell, et al.
The Lancet Regional Health. Western Pacific
|
June 26, 2023
A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: an retrospective cohort study in Fiji
Rita Reyburn, Evelyn Tuivaga, Tupou Ratu, et al.
Plos Medicine
|
November 12, 2019
Oxygen systems to improve clinical care and outcomes for children and neonates: A stepped-wedge cluster-randomised trial in Nigeria
Hamish R Graham, Ayobami A Bakare, Adejumoke I Ayede, et al.
Vaccines
|
December 5, 2019
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
Zheng Quan Toh, Jennie Kosasih, Fiona M Russell, et al.
The Lancet Regional Health. Western Pacific
|
December 25, 2023
Impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia hospitalisations in Mongolia: a time series analysis
Kirsten Fagerli, Munkhchuluun Ulziibayar, Bujinlkham Suuri, et al.
Vaccine
|
December 4, 2018
Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
Catherine Satzke, Eileen M Dunne, Molina Choummanivong, et al.
The Lancet Regional Health. Western Pacific
|
September 16, 2021
Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study
Jocelyn Chan, Tuya Mungun, Purevsuren Batsaixan, et al.
Plos One
|
April 3, 2020
Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys
Eleanor F G Neal, Cattram D Nguyen, Felista T Ratu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2016
Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study
Zheng Quan Toh, Fiona M Russell, Rita Reyburn, et al.
The Lancet. Microbe
|
November 1, 2024
Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2-59 months in Mongolia: an active pneumonia surveillance programme
Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar, et al.
Page
of 5